FDA product code LFZ: Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
LFZ is the FDA product code for enzyme linked immunoabsorbent assay, cytomegalovirus. It is a Class II device, regulated under 21 CFR 866.3175 and reviewed by the Microbiology panel. FDA has cleared 58 510(k) submissions under LFZ, 2 in the last five years, from 30 different applicants. The average 510(k) review took 198 days (median 172). FDA has posted 9 recalls for LFZ devices, 2 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus |
| Device class | Class II |
| Regulation | 21 CFR 866.3175 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
510(k) clearances per year for LFZ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 81 |
| 2018 | 1 | 84 |
| 2022 | 2 | 203 |
Compare with all 510(k) review times · Search every LFZ clearance
Top LFZ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Abbott Laboratories | 6 | 2022-10-27 |
| Zeus Scientific, Inc. | 5 | 1999-01-11 |
| Behring Diagnostics, Inc. | 5 | 1996-10-09 |
| Roche Diagnostics | 4 | 2022-10-12 |
| Gull Laboratories, Inc. | 4 | 1992-02-14 |
25 more applicants have LFZ clearances. See the full list in Caduvo.
Most recent LFZ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K220949 | Abbott Laboratories | Architect CMV IgG | 2022-10-27 | 209 |
| K220911 | Roche Diagnostics | Elecsys CMV IgG | 2022-10-12 | 197 |
| K181213 | Siemens Healthcare Diagnostics, Inc. | ADVIA Centaur CMV IgG and ADVIA Centaur CMV IgG Quality Control | 2018-07-30 | 84 |
| K163569 | Roche Diagnostics | Elecsys CMV IgM | 2017-03-17 | 88 |
| K162969 | DiaSorin, Inc. | LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set | 2017-01-06 | 74 |
Recalls for LFZ devices
9 product recalls in 9 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2025-11-03.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Frequently asked questions
What is FDA product code LFZ?
LFZ is the FDA product code for enzyme linked immunoabsorbent assay, cytomegalovirus. It is a Class II device, regulated under 21 CFR 866.3175 and reviewed by the Microbiology panel.
What device class is LFZ?
Class II, regulation 21 CFR 866.3175. Typical premarket route: 510(k).
How long does a 510(k) take for product code LFZ?
Across 58 cleared submissions the average was 198 days from receipt to decision (median 172).
Which companies have the most LFZ clearances?
Abbott Laboratories (6); Zeus Scientific, Inc. (5); Behring Diagnostics, Inc. (5); Roche Diagnostics (4); Gull Laboratories, Inc. (4).
Have LFZ devices been recalled?
Yes: 9 product recalls across 9 recall events; the most recent began 2025-11-03.
Next steps
- Run an FDA pathway report with predicate devices for product code LFZ
- Run a recall and safety report across every LFZ manufacturer
- Watch product code LFZ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times